2026 CERTIFIED TRADE MISSION TO

Oslo

Join us on June 9th, 2026

Register Here

Agenda

Tuesday, June 9, 2026

Hotel Continental Oslo Stortingsgata 24/26, 0117 Oslo, Norway

11:00 - 12:00 Buffet Networking Lunch with GP's

12:00 - 15:30 Members of the US delegation will meet with Norwegian investment professionals including institutional investors and family offices

16:00 - 18:00 U.S. Embassy sponsored LP-GP Networking Reception

Accomodations

TRADE MISSIONS
GP FUNDS
There will be a total of 12-15 US funds. They will be registering over the next few months. Please check back for updates

BITKRAFT Ventures

Venture Capital

Our perspective on the future of the industries in which we invest - gaming, AI, Web3, and immersive technology - is anchored around a thesis of Synthetic Reality: that the convergence of physical and digital worlds will continuously introduce new human experiences and create unprecedented social and economic opportunities. We currently serve a global portfolio of over 125 forward-thinking startups, each contributing to the construction of the virtual worlds and economies of tomorrow.

HX Venture Fund

Venture Capital

HX Venture Fund is a venture capital fund of funds that creates a multiplier effect by linking the transformational power of world-class corporations, technology innovation, and high-growth startups with proven venture investment talent, company-building expertise, and capital.

TLA.vc

Venture Capital

The "Enterprise Readiness" VC firm for early-stage AI startups, investing across the US, Europe, and Israel. A collaboration between the Co-Founder of Microsoft's VC arm and a 3-time Unicorn MD/CRO, we're 'Bringing Expertise to Brilliance' and supporting exceptional founders not just with capital, but with the ability and readiness to land trajectory-changing Enterprise customers as early as Pre-Seed, helping them secure a category-leader position.

SGA Capital

Venture Capital

SGA Capital is a growth equity firm backing technology businesses where hardware and software combine to solve structural problems in large markets. We invest at Series B and beyond across four core verticals (energy transition, mobility, robotics, and aerospace) at the inflection point where companies have established product-market fit and a clear line of sight to commercial scale. SGA today runs a deal-by-deal SPV model with meaningful GP commitment in every investment. The intent is to transition to a discretionary fund over the coming years once the track record supports the necessary fund size, with a long-term vision of a platform built around performance discipline rather than AUM growth.

PraCon Global Investment Group

Venture Capital

PraCon Global Investment Group invests in undervalued assets and transformational companies in the verticals of Finance, Agriculture, Technology, Energy, Real Estate, Healthcare, and Automotive. Our approach is simple. We are looking for Startups, Mature Firms, Portfolios of Assets, and Individual assets that are innovative and within our verticals. If you think that investing capital in your venture will produce a transformational company, please reach out to us.

Vycellix

Company

Vycellix, Inc. is a privately-held biopharmaceutical company developing innovative products capable of optimizing human immune response against disease with a focus on cancers. The Company is advancing its proprietary pipeline of novel immunodudulators as therapeutics for cancers and infectious disease, as well as establishing these molecules as platform technology for the efficient, cost effective modulation of cell and gene therapies.

Charge Oasis LLC

Company

Charge Oasis is redefining EV infrastructure by fixing a core issue: the industry has scaled supply, not demand. Most charging networks focus solely on electricity delivery, a commoditized, low-margin model with low utilization. Charge Oasis introduces amenities to create true destination charging, turning a 20 to 40 minute stop into a high-value customer experience by integrating premium retail, food and beverage, hospitality, and digital engagement elements at each site.

Retro Biosciences

Company

Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to rejuvenate cell and tissue function with the ultimate aim of adding 10 years to healthy human lifespan.

EVENT CO-CHAIR(S)

Peter Hammerich

Peter Hammerich

Partner - BAHR Asset Management & Private Equity

Peter Hammerich has been a partner and head of BAHR's Asset Management & Private Equity practice group since 2005, a group currently consisting of around 40 lawyers specialising in asset management. Peter advises leading Scandinavian asset managers, including fund managers within all alternative asset classes, financial institutions, investment banks, insurance companies, pension funds, and sovereign wealth funds. He is frequently instructed on compliance, fundraising, human capital, ESG/sustainability, M&A, tax and regulatory matters, as well as disputes involving asset managers. He is recognised in independent ratings as one of the leading Nordic legal advisors for asset managers. Peter is an active participant in regulatory discussions and policy matters affecting the Norwegian asset management industry, and a frequent speaker at seminars. He is chairman of the Norwegian Alternative Investment Association and chairman of several of the leading asset managers in Norway.
Read Bio
Jonathan Uggedal

Jonathan Uggedal

Partner - BAHR Asset Management & Private Equity

Jonathan Uggedal is a partner and deputy head of BAHR’s Asset Management & Private Equity practice group. Since starting his career in 2010, Jonathan has been advising asset managers in Norway and abroad on the legal aspects of their businesses. He has a particular focus on Scandinavian and cross- border private M&A for private equity sponsors and other asset managers, as well as fund formation, fund M&A, fund financing and other capital solutions tailored for asset managers. He acts for managers within PE, venture, real estate and other alternative assets, and is noted as a next generation partner by independent rankings.
Read Bio

U.S. DEPARTMENT OF COMMERCE

Brian N. Beams

Brian N. Beams

Director, Global Financial Services Team Senior International Trade Specialist U.S. Commercial Service

Vidar Keyn

Vidar Keyn

Head of Section, U.S. Commercial Service, U.S. Embassy - Oslo, Norway

Claudia Ursulescu Kracht

Claudia Ursulescu Kracht

Commercial Specialist, U.S. Commercial Service, U.S. Embassy - Oslo, Norway

TESTIMONIAL

“I thought the Trade Mission was one of the most unique fundraising assets I’ve ever seen. The ability to have 50+ warm leads provided over the course of 1 day is phenomenal. It would have been impossible for our fund to have done anything like this ourselves and I doubt any financial service organizations could have provided a stronger group. I would highly recommend the Trade Mission, not just because of the quantity of potential investors but the quality of investors.”

– Maxx Bricklin, Principal, Bold Capital Partners, LP

U.S. Department of Commerce Certified Trade Mission:

Introductions to Leading U.S. Alternative Asset Fund Managers

This Trade Mission is arranged exclusively for investors seeking to meet with leading U.S. fund managers.

Register Now

To learn more please schedule a call with Jacob Katsof

Schedule a Call

To learn more please schedule a call with Irwin Katsof, Managing Director of Trade Missions

Schedule a Call